Abstract Details
| Peter A. Ljubenkov, MD (UCSF Department of Neurosciences, Division of Neurology) | Dr. Ljubenkov has nothing to disclose. |
| Alan M. Rapoport, MD, FAAN | Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie, Amgen, Biohaven, Cala Health, Satsuma, Teva Pharmaceutical Industries, Theranica, Xoc and Zosano. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Amgen, Biohaven, Lundbeck and Teva Pharmaceutical Industries. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Reviews. |
| Rima Alkasem, MD (Global Neurosciences Institute) | No disclosure on file |
| No disclosure on file | |
| Mercedes P. Jacobson, MD (Temple University) | The institution of Dr. Jacobson has received research support from Engage. The institution of Dr. Jacobson has received research support from XENON. The institution of Dr. Jacobson has received research support from SK Life Sciences. |
| Sayed A. Azizi, MD, PhD, FAAN (Yale University School of Medicine) | No disclosure on file |
| No disclosure on file |